Navigation Links
Another Medtronic Sprint Fidelis Lead Lawsuit is Filed in Federal District Court
Date:11/5/2007

ent is used in cardiac defibrillators -- or complex devices with defibrillation capacity -- and not in conventional pacemakers. Some patients with congestive heart failure use devices that include this defibrillation ability, and those are among the devices that use the Sprint Fidelis Lead.

Medtronic's Sprint Fidelis Leads have been shown to have a continuing fracture problem. This defect can cause the defibrillators to deliver a massive and painful electrical shock, or it can cause the device to fail to administer a lifesaving shock when necessary. These defects were highlighted in an article written by doctors at The Minneapolis Heart Institute, one of the premier cardiac institutions in the world. The researchers at the Minneapolis Heart Institute compared data regarding lead failures in both the Sprint Fidelis models and Medtronic's earlier Sprint Quattro models. The study concluded that the thinner Sprint Fidelis Lead had a higher chance of fracturing than the Sprint Quattro. According to Medtronic's own estimate, approximately 2.3%, or 4,000 to 5,000 people with a Sprint Fidelis Lead will experience a lead fracture within 30 months of implantation.

When a Sprint Fidelis Lead fractures, a patient must undergo a surgical procedure that can tear and scar the heart tissue and veins through which the

Sprint Fidelis Lead wire runs. The surgery to replace a defibrillator lead wire is far riskier than having the device which it is attached to replaced.

If you or a loved one received a Sprint Fidelis Lead as part of your implantable defibrillator, please contact the Parker Waichman Alonso LLP claims center by visiting http://www.medtronicdefectlawsuit.com or by calling 1-800- LAW-INFO (1-800-529-4636).

About Parker Waichman Alonso LLP:

Parker Waichman Alonso LLP is a leading products liability and personal injury law firm that represents plaintiffs nationwide. The firm
'/>"/>

SOURCE Parker Waichman Alonso LLP
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Another Reason Not to Smoke While Pregnant: Birth Defects
2. One Species Genome Found Within Another
3. Eat Seafood, See Weight Loss: Recent Study Finds Another Reason to Eat Seafood for a Fit Lifestyle
4. Message for Activists at Latino National Congreso Convention: Amnesty Will Exacerbate National Problems and Turn the U.S. into Another Mexico
5. Latest Edition of Ripon Forum Highlights Schwarzeneggers Leadership on Another Challenge Facing his State - Health Care
6. Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
7. Portico(TM) Systems Charts Another Period of Rapid Growth
8. Kyphon Announces Special Meeting Date to Vote on Proposed Medtronic Merger
9. The Law Offices of John David Hart: Texas Man Sues Medtronic in Body-Snatching Case
10. Amicus Brief Filed with U.S. Supreme Court in Riegel v. Medtronic, Inc.
11. Medtronic Sprint Fidelis Defibrillator Lead Lawsuit Claims Center Opens to Aid Victims
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Agoura Hills dentist , Dr. Amir ... Zoom Whitening is one of the most powerful whitening treatments ... professional. This light-assisted treatment uses a prescription-strength gel that can ... to break up stains that are in both the enamel ... soft drink and tobacco stains. , About Dr. Amir ...
(Date:7/25/2014)... 25, 2014 Garth Brooks Chicago tickets ... Allstate Arena in Rosemont. Garth Brooks was one of the ... his first single in 1989. Since "Much Too Young (To Feel ... shows from the Tulsa, Okl. native and in the years that ... him back on a stage and in the recording studio. Between ...
(Date:7/25/2014)... An alpha olefin is an olefin or ... or alpha position of the carbon chain, or between the ... alpha-olefins, namely, branched and linear (or normal). The alpha olefin ... of its applications such as polyethylene co-monomers and synthetic lubricants, ... and Europe have been lucrative markets for alpha olefins; however, ...
(Date:7/25/2014)... more quickly after Manchester research , Clinical judgement, ... on arrival, is effective in reducing unnecessary hospital ... The findings of a research group in Manchester, ... make a huge difference to a large number ... reason for emergency hospital admission. In Manchester, the ...
(Date:7/25/2014)... cancer screening test results among some patients is real ... et al, published July 25 in Cancer , ... positive or other results of computed tomography (CT) lung ... some in the medical community. , "Unsubstantiated claims ... put to rest and not continue to delay implementation ...
Breaking Medicine News(10 mins):Health News:Agoura Hills Dentist, Dr. Amir Choroomi, is Now Offering a Promotion on Zoom Whitening 2Health News:Garth Brooks Chicago Tickets for Performance at Allstate Arena in Rosemont Go On Sale July 25th 2Health News:Garth Brooks Chicago Tickets for Performance at Allstate Arena in Rosemont Go On Sale July 25th 3Health News:Europe Alpha Olefins Market is Expected to Reach $1,958 Million in 2018 - New Report by MicroMarket Monitor 2Health News:Europe Alpha Olefins Market is Expected to Reach $1,958 Million in 2018 - New Report by MicroMarket Monitor 3Health News:Heart attack patients could be treated more quickly after Manchester research 2Health News:ACR statement on cancer study regarding patient anxiety from CT lung cancer screening 2
... outbreaks reported from Vietnam and South Korea has put ... stocked and ready to deal with the situation, if ... Ministry has a stock of 2.5 million capsules of ... doses of influenza vaccines to be given to risk ...
... autoimmune disorder marked by early skin lesions and ... this thickening and hardening of connective tissue affects ... and the heart. In SSc patients, fibrosis frequently ... Researchers have yet to determine the underlying cause ...
... New York: A new study has shown a connection ... breast cancer after menopause//. While there is little doubt that ... seems to be convincing evidence that weight gain in adult ... disease. , ,Yet, not much was known about the ...
... A California based company has developed a pill called Excalia ... researchers working for this announced// the results ... the North American Association for the Study of Obesity.This organisation ... obesity. They claim that this preparation can effectively help ...
... Bharatiya Janta Party has been inspired from the most ... family planning programme for the Muslim community// based on ... and clerics for awareness campaign as well as the ... the way of family planning is ignorance and not ...
... prompt women to both scale back risky drinking and ... ,Prenatal alcohol exposure is a leading preventable cause ... States. This CDC study explored a strategy that could ... ,“A lot of people find this to be ...
Cached Medicine News:Health News:New Treatment Offers Hope for Systemic Sclerosis 2Health News:Madhya Pradesh Imbibes Family Planning Lessons from Pakistan 2Health News:Counseling Helps Young Women Cut Drinking, Improve Contraception Use 2Health News:Counseling Helps Young Women Cut Drinking, Improve Contraception Use 3
(Date:7/24/2014)... -- Uroplasty, Inc. (NASDAQ: UPI ), a medical ... proprietary products to treat voiding dysfunctions, today reported ... ended June 30, 2014.  Global revenue for ... 19% to $4.1 million, as compared to $3.4 ... year.  Total revenue for the fiscal first quarter ...
(Date:7/24/2014)... July 24, 2014  Mettler-Toledo International Inc. (NYSE: ... 2014.  Provided below are the highlights: , ... quarter compared with the prior year. Reported sales increased ... , Net earnings per diluted share as reported (EPS) ... of 2013. Adjusted EPS was $2.57, an increase of ...
(Date:7/24/2014)... 24, 2014 Amgen (NASDAQ: AMGN ) ... results on Tuesday, July 29, 2014, after the close of ... a conference call with the investment community at 2 p.m. ... Robert A. Bradway , chairman and chief executive officer, and ... audio of the conference call will be simultaneously broadcast over ...
Breaking Medicine Technology:Uroplasty Reports Fiscal First Quarter Results 2Uroplasty Reports Fiscal First Quarter Results 3Uroplasty Reports Fiscal First Quarter Results 4Uroplasty Reports Fiscal First Quarter Results 5Uroplasty Reports Fiscal First Quarter Results 6Uroplasty Reports Fiscal First Quarter Results 7Uroplasty Reports Fiscal First Quarter Results 8Uroplasty Reports Fiscal First Quarter Results 9Uroplasty Reports Fiscal First Quarter Results 10Uroplasty Reports Fiscal First Quarter Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 2Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 3Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 4Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 5Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 6Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 7Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 8Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 9Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 10Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 11Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 12Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 13Mettler-Toledo International Inc. Reports Second Quarter 2014 Results 14Amgen Announces Webcast of 2014 Second Quarter Financial Results 2
... March 12 Genta,Incorporated (Nasdaq: GNTA ) today announced ... 31, 2007. The Company noted,significant recent milestones, including:, ... biomarker initiates in melanoma -- New oral product, ... 505(b)(2) strategy -- Tesetaxel, a leading ...
... Achieve Weight Loss with Education & ... ... Findings in the Journal of,the American Medical Association on the largest ... prevention.,The combination of both personal contact and web-based support are,identified as ...
Cached Medicine Technology:Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 2Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 3Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 4Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 5Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 6Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 7Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 8Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 9Genta Incorporated Announces Fourth Quarter and Year End 2007 Financial Results and Corporate Highlights 10Study Finds Personal and Web-Based Support Equal Weight Loss Success 2Study Finds Personal and Web-Based Support Equal Weight Loss Success 3Study Finds Personal and Web-Based Support Equal Weight Loss Success 4
... ophthalmic solution is an anti-infective ... doctor may instruct you to ... eye infection caused by bacteria. ... are the 2 types of ...
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
ALPHAGAN® P (brimonidine tartrate ophthalmic solution) 0.15% is medication in the form of an eye drop that is used to lower the pressure inside your eye(s), also referred to as intraocular pressu...
ALOCRIL® ophthalmic solution is a prescription eye drop for itchy allergy eyes. ALOCRIL® provides control beyond relief by providing continuous symptom control throughout the allergy season....
Medicine Products: